15/10/2020
The Applications of Engineering in Medicine and Biology seminar series continues with John Bischof’s "Nanowarming for Regenerative Medicine" seminar on October 21, 2020.
The Applications of Engineering in Medicine and Biology seminar series 2020-2021 Fall Program is as below:
7 October 2020 – BAŞAK UYGUN – Engineering Organ Substitutes for Transplantation
21 October 2020 – JOHN BISCHOF – Nanowarming for Regenerative Medicine
4 November 2020 – GUILLERMO AGUILAR – From Laser Dermatology to the Development of a Transparent Cranial Implant
18 November 2020 – EBRU ORAL – Engineering Joint Implants for in vivo Longevity and Antibacterial Treatment
2 December 2020 – MEHMET TONER – “EXTREME MICROFLUIDICS” Label-Free Sorting of Extremely Rare Circulating Tumor Cells and Clusters
16 December 2020 – DANIEL IRIMIA – Chain Reactions in Immunology
Please click here to register The Applications of Engineering in Medicine and Biology seminar series.
John Bischof
John Bischof works in the area of thermal bioengineering with a focus on biopreservation, thermal therapy, and nanomedicine. His awards include the ASME Van Mow Medal and Fellowships in societies including Cryobiology, JSPS, ASME, and AIMBE. He has served as the President of the Society for Cryobiology and Chair of the Bioengineering Division of the ASME. Bischof obtained a B.S. in Bioengineering from U.C. Berkeley (UCB) in 1987, an M.S. from UCB and U.C. San Francisco in 1989, and a Ph.D. in Mechanical Engineering from UCB in 1992. After a Post-doctoral Fellowship at Harvard in the Center for Engineering in Medicine, he joined the University of Minnesota in 1993. John Bischof is now a Distinguished McKnight University Professor, Kuhrmeyer Chair in the Departments of Mechanical and Biomedical Engineering, and the Medtronic-Bakken Endowed Chair and Director of the Institute for Engineering in Medicine at the University of Minnesota. John Bischof is also Director of the NSF Engineering Research Center Advanced Technologies for Preservation of Biological Systems (ATP-Bio), which launched on September 1, 2020.